Corporate Tech Investors

Dexcel Pharma

Dexcel Pharma is a corporate VC investing group that makes equity investment in firms that align with the company's business objectives.

Venture Investor Overview

Contact Information

Background Information

Overview

Dexcel Pharma is Israel's largest private pharmaceutical company. Founded in 1968, we develop, manufacture and market value-added branded and generic pharmaceuticals. With a diverse product portfolio that spans more than 85 branded and generic products in over 175 dosage forms, our products are sold in the US, the UK and Germany, via subsidiaries and through a trusted network of partners in more than 30 countries worldwide.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

5/16/2022

Transaction History

Our records indicate that Dexcel Pharma invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Ilan Oren

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Dexcel Pharma has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

DevFactory | Dexcom

Share this article

About Our Corporate Tech Investing Database

This corporate tech investor profile is powered by VentureDeal.com, a leading provider of corporate tech investing transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary